Picture of Mochida Pharmaceutical Co logo

4534 Mochida Pharmaceutical Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Annual cashflow statement for Mochida Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6,27311,90014,5919,0446,160
Depreciation
Non-Cash Items2,552305127-760-439
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,209-5,751-9,947-3,659-16,009
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities9,3479,1967,4607,297-7,480
Capital Expenditures-1,958-1,935-2,988-2,166-2,296
Purchase of Fixed Assets
Other Investing Cash Flow Items1981,055981-7832,370
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,760-880-2,007-2,94974
Financing Cash Flow Items0-100-14
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities-5,328-5,112-5,956-6,884-6,393
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,2593,195-472-2,504-13,720